Press Releases

Friday, December 15th, 2000

Nortran Announces Cough Trial Results


Monday, November 6th, 2000

Nortran Update and Third Quarter Results


Monday, October 16th, 2000

Nortran Signs Licensing Agreement with AstraZeneca


Wednesday, August 2nd, 2000

Nortran Reports Second Quarter Results


Monday, July 24th, 2000

Nortran to Commence Trading on Toronto Stock Exchange


Monday, July 17th, 2000

Nortran to Conditionally List on Toronto Stock Exchange


Tuesday, June 20th, 2000

Nortran Files Final Prospectus for $7.8 Million Special Warrant Financing


Monday, June 5th, 2000

Nortran Closes $0.5 Million Private Placement


Wednesday, May 24th, 2000

Nortran To Complete $0.5 Million Private Placement


Monday, May 1st, 2000

Nortran Reports First Quarter Results